Published in Ann Intern Med on July 01, 1976
Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res (1987) 1.11
Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis. Am J Pathol (1977) 0.95
Suppressive effect of IgE soluble immune complex on neutrophil chemotaxis. Clin Exp Immunol (1983) 0.79
Theophylline therapy inhibits neutrophil and mononuclear cell chemotaxis from chronic asthmatic children. Br J Clin Pharmacol (1991) 0.76
Immunity in diabetes mellitus: impaired or enhanced? West J Med (1979) 0.75
Transfer factor therapy in hyperimmunoglobulinaemia E syndrome. Clin Exp Immunol (1979) 0.75
A child with atopic features, raised serum IgE, and recurrent infection treated with levamisole. Arch Dis Child (1981) 0.75
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med (2001) 5.67
Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat Med (2001) 4.09
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med (1977) 3.61
Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest (1976) 3.04
Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis (2005) 2.61
Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr (1994) 2.52
Cyclic GMP and cell movement. Nature (1973) 2.46
Rapid identification of group B streptococci by counterimmunoelectrophoresis. J Clin Microbiol (1975) 2.45
Psoriasis assessment tools in clinical trials. Ann Rheum Dis (2005) 2.24
Precision and accuracy of commercial laboratories' ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol (2001) 2.23
Topical aminocaproic acid in the treatment of traumatic hyphema. Arch Ophthalmol (1997) 2.14
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis (2005) 2.08
High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol (1996) 2.00
Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet (1974) 1.98
Epidemic of pharyngitis due to streptococci of Lancefield group G. Lancet (1969) 1.78
Nosocomial colonization with Klebsiella, type 26, in a neonatal intensive-care unit associated with an outbreak of sepsis, meningitis, and necrotizing enterocolitis. J Pediatr (1974) 1.78
Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate. Metabolism (1975) 1.78
Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome. J Pediatr (2000) 1.74
Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr (1991) 1.68
The current status of intravenous gamma-globulin use in neonates. Pediatr Infect Dis J (1989) 1.66
Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun (2007) 1.59
Assessment of the virulence factors of group B streptococci: correlation with sialic acid content. J Infect Dis (1983) 1.58
Role of antibody and complement in opsonization of group B streptococci. Infect Immun (1978) 1.57
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J Immunol (1985) 1.56
Site of action of cortisol in cellular immunity. J Immunol (1973) 1.46
Differential expression of Ia by murine keratinocytes and gut epithelium in response to recombinant gamma-interferon. J Invest Dermatol (1989) 1.46
Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis. J Eur Acad Dermatol Venereol (2012) 1.46
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45
The effects of phosphate, pH, and AS volume on RBCs stored in saline-adenine-glucose-mannitol solutions. Transfusion (2000) 1.40
Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators. J Immunol (1977) 1.40
Thioguanine for refractory psoriasis: a 4-year experience. J Am Acad Dermatol (2001) 1.38
Anaphylaxis to piñon nuts. Ann Allergy (1990) 1.37
A blinded, multi-center evaluation of two commercial in vitro tests for latex-specific IgE antibodies. Ann Allergy Asthma Immunol (2000) 1.37
Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann Intern Med (1975) 1.36
mu-Chains from a nonsecretor B cell line differ from secreted mu-chains at the C-terminal end. J Immunol (1978) 1.36
Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors. Immunology (1980) 1.35
The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis (1991) 1.34
Strain specificity of opsonins for group B streptococci types II and III. Infect Immun (1979) 1.33
Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. Biochem J (1991) 1.31
Hyperactivity of neutrophil leukotactic responses during active bacterial infection. J Clin Invest (1974) 1.29
Multiplex analysis of heterophil antibodies in patients with indeterminate HIV immunoassay results. Am J Clin Pathol (2001) 1.28
Chemiluminescence by polymorphonuclear leukocytes from patients with active bacterial infection. J Infect Dis (1980) 1.26
Use of the directigen latex agglutination test for detection of Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis antigens in cerebrospinal fluid from meningitis patients. J Clin Microbiol (1984) 1.25
Pneumonia in the neonate associated with group B streptococcal septicemia. Am J Dis Child (1976) 1.24
Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. J Pediatr (1979) 1.24
An evaluation of the effectiveness of three immunoglobulin G (IgG) removal procedures for routine IgM serological testing. Clin Diagn Lab Immunol (1995) 1.22
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum (2007) 1.21
Inflammatory mediators stimulate granulocyte adherence to cultured human endothelial cells. Thromb Res (1984) 1.19
Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr (1993) 1.18
Human endothelial cells modulate granulocyte adherence and chemotaxis. J Immunol (1985) 1.18
Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. Proc Natl Acad Sci U S A (1983) 1.18
Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus. Am J Clin Pathol (2001) 1.17
Purification of the proteinase from group B streptococci that inactivates human C5a. Biochim Biophys Acta (1991) 1.17
Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species. Infect Immun (1993) 1.15
Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci. J Infect Dis (1984) 1.15
Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J (1997) 1.15
Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity. J Immunol (1988) 1.15
Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus. J Infect Dis (1984) 1.15
Long-term maintenance of psoriatic human skin on congenitally athymic (nude) mice. J Invest Dermatol (1975) 1.14
Functional and metabolic activity of granulocytes from patients with adult respiratory distress syndrome. Evidence for activated neutrophils in the pulmonary circulation. Am Rev Respir Dis (1983) 1.14
Effect of chemoattractants on chemiluminescence. Infect Immun (1978) 1.14
Correction of a developmental defect in neutrophil activation and movement. Am J Pathol (1987) 1.13
Isotretinoin treatment of Darier's disease. J Am Acad Dermatol (1982) 1.13
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
Topical metronidazole maintains remissions of rosacea. Arch Dermatol (1998) 1.12
A new method for detecting Plasmodia. Mil Med (1971) 1.12
Screening for antinuclear antibodies by enzyme immunoassay. Am J Clin Pathol (1996) 1.12
Role of Ca2+ and Mg2+ in some human neutrophil functions as indicated by ionophore A23187. Infect Immun (1976) 1.11
Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol Med Microbiol (1993) 1.11
Neurologic, intellectual, and psychologic sequelae following western encephalitis. A follow-up study of 35 cases. Neurology (1971) 1.09
Food-borne epidemic of streptoccal pharyngitis at the United States Air Force Academy. N Engl J Med (1969) 1.09
A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis (1997) 1.09
IgA antibodies against endomysium and transglutaminase: a comparison of methods. J Clin Lab Anal (2001) 1.08
Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis. J Lab Clin Med (1976) 1.08
Return of rheumatic fever: consequences, implications, and needs. J Pediatr (1987) 1.08
Evaluation of nonspecific (alternative pathway) opsonic activity by neutrophil chemiluminescence. Int Arch Allergy Appl Immunol (1977) 1.08
Epigastric bruits in patients with and without celiac axis compression. A phonoarteriographic study. Ann Intern Med (1973) 1.08
Stevens-Johnson syndrome associated with Mycoplasma pneumoniae infections. Arch Dermatol (1978) 1.08
Helix bending in alamethicin: molecular dynamics simulations and amide hydrogen exchange in methanol. Biophys J (1997) 1.07
Expression of Ia antigen on epidermal keratinocytes after the grafting of normal skin to nude mice. J Immunol (1983) 1.07
Leukotactic activity and reduction of nitroblue tetrazolium by neutrophil granulocytes from patients with streptococcal skin infection. J Infect Dis (1974) 1.05
The face of Job. J Pediatr (1998) 1.05
The candida precipitin test in an immunosuppressed population. Cancer (1979) 1.05
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis. Ann Rheum Dis (2005) 1.05
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Ann Rheum Dis (2006) 1.05
Rabies in rabbits and mice: protective effect of polyriboinosinic-polyribocytidylic acid. J Infect Dis (1972) 1.04
Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium. J Immunol (1991) 1.03
Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and 'reverse' Koebner reactions. Br J Dermatol (1982) 1.03
Inflammatory and immune cell function in psoriasis--a subtle disorder I. In vivo and in vitro survey. J Invest Dermatol (1978) 1.03
Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci. Infect Immun (2000) 1.03
Heterophile antibodies to bovine and caprine proteins causing false-positive human immunodeficiency virus type 1 and other enzyme-linked immunosorbent assay results. Clin Diagn Lab Immunol (1999) 1.03
Comparison of topical steroids for acute anterior uveitis. J Ocul Pharmacol Ther (2004) 1.02
Neonatal cellular and humoral immunity to group B streptococci. Pediatrics (1979) 1.02
Inflammatory and immune cell function in psoriasis: II. Monocyte function, lymphokine production. J Invest Dermatol (1978) 1.02
Effects of group B streptococci on cord and adult mononuclear cell interleukin-12 and interferon-gamma mRNA accumulation and protein secretion. J Infect Dis (2000) 1.01
Influence of phenylbutazone on leukocyte chemiluminescence and function. Acta Pathol Microbiol Scand C (1978) 1.00
Molecular mechanism of RNA-phage morphogenesis. Biochem Soc Trans (1993) 1.00
Comparison of commercially available enzyme immunoassay with traditional serological tests for detection of antibodies to Coccidioides immitis. J Clin Microbiol (1995) 1.00